ClinicalTrials.Veeva

Menu

Diagnostic Accuracy to Detect Hemodynamically Significant Stenosis by Non-invasive SURECardio CT-FFR

T

Toshiba Medical Systems

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Device: CT-FFR. CTA. FFR

Study type

Observational

Funder types

Industry

Identifiers

NCT03055780
SGD03-0667

Details and patient eligibility

About

The aim of this study was to determine the diagnostic accuracy of SURECardio CT-FFR to detect functionally significant coronary stenosis.

Full description

CT acquision and invasive FFR measurement is performed for each patients. The diagnostic accuracy of coronary CTA and SURECardio CT-FFR is investigated using Invasive FFR is used as the reference standard.

Enrollment

59 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • suspected coronary artery disease
  • hemodynamically stable condition

Exclusion criteria

  • hemodynamic instability
  • atrial fibrillation
  • morbid obesity (BMI≥40 kg/m2)
  • previous stent implantation
  • recent myocardial infarction (within 30 days)
  • age <40 years
  • renal insufficiency (eGFR <60mL/min/1.73m2)
  • bronchospastic lung disease requiring long term steroid therapy

Trial design

59 participants in 1 patient group

CT-FFR. CTA. FFR
Description:
59 patients with suspected CAD that have been scheduled for an interventional FFR study
Treatment:
Device: CT-FFR. CTA. FFR

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems